Medical and Health Sciences | Article | Published 2024

"THE CONCEPT OF FATTY LIVER DISEASE ASSOCIATED WITH METABOLIC SYNDROME"

Authors:

Инобат Ахмедова

Наила Худайберганова

Малика Саидмуродова

Гулноза Рахматуллаева

Collection: Web of medicine, juornal of medicine, practice and nursing Volume 2, Issue 8, August 2024 ISSN (E): 2938-3765
Keywords: fatty hepatosis, metabolic syndrome.

Abstract

Fatty hepatosis is the most common chronic liver disease. According to statistics, non–alcoholic fatty liver disease is found in 6.3-33% of adults worldwide. In obese patients, this figure is even higher: it reaches 62-93%. The peak incidence in both men and women occurs at the age of 40-50 years. The mechanism of development of fatty hepatosis is quite complex and includes environmental factors (nutrition and physical activity of a person), hormonal background, genetic prerequisites. Normally, lipids should be transformed in the liver into other substances necessary for the proper functioning of the digestive system. But instead, they penetrate into the hepatocytes and accumulate there. The liver tissue in the areas of fatty infiltration becomes dense and can no longer perform its tasks. Steatosis develops - the initial stage of non-alcoholic fatty liver disease.

References

  1. Agofonova N.A., Volosheynikova T.V., Erigoryeva V.T., Yakovenko E.P. Metabolic liver
  2. diseases: non-alcoholic steatosis and steatohepatitis. Diagnostics and treatment. // Bol. org.
  3. pishchev. - 2004. - №2. http// www.pro-medicine.ru.
  4. 2. Batskov S.S. Fatty hepatitis - ways of pharmacological correction. // Materials of the symposium
  5. “Essential phospholipids in the treatment of liver damage”. - Moscow, 1997. - P.19-21.
  6. 3. Bueverov A.O. Fatty liver: causes and consequences. // Popular medicine journal. - 2002. - T.
  7. 1, No. 4. http:/ /www.consilium-medicum.com.
  8. 4. Bueverov A.O., Maevskaya M.V. Some pathogenetic and clinical issues of non-alcoholic
  9. steatohepatitis. // Clinical prospects of gastroenterology, hepatology. - 2003. - No. 3. - P.2-7.
  10. 5. Viter V., Permyakov A.V., Naumov E.S., et al. Variants of thanatogenesis in acute alcohol
  11. intoxication. // Current aspects of forensic medicine. - 1999. - No. 5. - P. 128-133. Eorshteyn E.S., Dudnik L.B., Maiore A.Ya., et al. Changes in the functional state of subcellular
  12. structures of hepatocytes in fatty hepatitis in clinical and experimental settings. // Advances in
  13. Hepatology / Ed. by A.F. Bluger. — Riga: Riga Medical Institute. — 1987. — P.158-173.
  14. 7. Grigoriev P.Y. Fatty hepatitis (fatty infiltration of the liver): diagnostics, treatment and
  15. prevention. // Bol. org. digestion. - 2002. - No. 1. - P.30-37.
  16. 8. Ivashkin V.T., Shulpekova Yu.O. Non-alcoholic steatohepatitis. // Bol. org. digestion. - 2000. -
  17. No. 2. - P. 41-45.
  18. 9. Kalinin A. V. Pathogenesis, clinical features and treatment of alcoholic liver disease. // Clinical
  19. prospects of gastroenterology, hepatology. - 2001. - No. 4. - P. 8-14.
  20. 10. Carneiro de Mura M. Non-alcoholic steatohepatitis. // Clinical perspectives of
  21. gastroenterology, hepatology. - 2001. - J№ 3. - P.12-15.
  22. 11. Kirsanova A.S., Edemskiy A.V. Gastrointestinal complications in cystic fibrosis in children
  23. and their treatment. http: //mucoviscidos.com.ua
  24. 12. Klimov A.N., Nikulcheva N.G. Lipid and lipoprotein metabolism and its disorders. // Manual
  25. for doctors. St. Petersburg: Piter Kom, 1999. - 504 p.
  26. 13. Komarov F.I., Khazanov A.I. Guide to Gastroenterology. - M.: Medicine, 1995. - P.22-23.
  27. 14. Maevskaya M.V., Bueverov A.O. Old and new approaches to the treatment of alcohol disease.
  28. // Rus. journal of gastroenterology, hepatology, proctology. - 2003. - J№ 6. - P.65-67.
  29. 15. Makarov V.K. Effect of alcohol on the lipid composition of blood serum in hepatitis B virus
  30. carriers. // Hygiene and Sanitation. - 2003. - J 1. - P.38-39.
  31. 16. Nikitin I.G., Storozhakov G.I., Fedorov I.G. et al. State of intestinal microflora in patients with
  32. non-alcoholic steatohepatitis. // RZHGGK. - 2002. - No. 5. - P.40-44.
  33. 17. Nimaeva D.E., Sizykh T.P. The nature of liver damage in type 2 diabetes mellitus. // Sib.med.
  34. zhurn. - 2002. - J№ 6. - P.14-21.
  35. 18. Okorokov A.N. Diagnostics of diseases of internal organs. - M.: Medical literature. - 2002. -
  36. P.380-410.
  37. 19. Panchenko V., Ershov A., Zimovchenko G. et al. Hepatoprotective effect of eikonal in fatty
  38. hepatosis. http: //www.trinita.ru.
  39. 20. Petukhov V.A., Karalkin A.V., Ibragimov T.I., et al. Liver dysfunction and dysbiosis in fatty
  40. hepatosis and lipid distress syndrome and their treatment with Duphalac (Lactulose). // Russ.
  41. gastroenterological journal. - 2001. - No. 2. - P.93-104.
  42. 21. Podymova S.D. Liver diseases. - M.: Medicine, 1993.- 538 p.
  43. 22. Popova Yu.P., Fedortsova Yu.P., Shevyakova L.V., Beyul E.A. Excess body weight at a young
  44. age - a risk factor for the development of metabolic diseases. // Nutrition issues. - M.: Medicine. -
  45. 1989. - JJ 1. - P.1-15.
  46. 23. Svintsitsky A.S., Revenok E.N., Solovieva G.A., Tkachuk A.I. Evaluation of the effectiveness
  47. of the drug Livolin forte in the treatment of patients with fatty hepatosis. http:// www.healthua.com.
  48. 24. Serov V.V. Morphological verification of chronic viral and alcoholic hepatitis. // RZHGGK. -
  49. 1998. - JJ 5. - P.26-29.
  50. 25. Serov V.V., Voinova L.V. Etiological and nosological assessment of liver pathology. // Rus.
  51. journal of gastroenterology, hepatology, proctology. - 2000. - JJ 2. - P.41-44.
Loading...
0

Views

0

Reads

0

Comments

0

Reviews

0

Liked

0

Shared

0

Bibliography

0

Citations

Like and share on

Cite this publication

Copy text below and use in your article